Idorsia Pharmaceuticals Ltd: QUVIVIQ (daridorexant) recommen

Idorsia Pharmaceuticals Ltd: QUVIVIQ (daridorexant) recommended for approval in Europe as a new treatment for adults with insomnia disorder

Ad hoc announcement pursuant to Art. 53 LR Idorsia receives a positive opinion from the Committee for Medicinal Products for Human Use for QUVIVIQ (daridorexant) for the treatment of adult patients

Related Keywords

Canada , Norway , Moscow , Moskva , Russia , Milan , Lombardia , Italy , United States , Allschwil , Switzerland General , Switzerland , United Kingdom , Texas , Colombo , Western , Sri Lanka , Liechtenstein , Northern Ireland , Craigavon , Baylor College Of Medicine , Germany , Iceland , Houston , Berlin , Italian , Great Britain , German , Swiss , American , Berliner Wirtschaftsgespr , Andrewc Weiss , Luigi Ferini Strambi , Cliffordb Saper , Ingo Fietze , Jean Paul Clozel , J Clin Pharmacol , American Psychiatric Association , World Association Of Sleep Medicine Society , European Sleep Research Society , World Sleep Federation , Disorders Center , Head Of The Interdisciplinary Center , Committee For Medicinal Products Human Use , Idorsia Ltd , Association For Pulmonologists , Italian Association Of Sleep Medicine , European Commission Decision Reliance Procedure , American Association Of Sleep Medicine , European Commission , Drug Administration , University Hospital Berlin , International Research Networks , Regulatory Agency , University Of Pittsburg , Journal Of Sleep Research , European Respiratory Society , Salute San Raffaele University , Head Of Investor Relations Corporate Communications , Department Of Neurology , German Sleep Society , Koch Metchnikoff Forum , European Union , German Sleep Foundation , European Union Member States , Study Group , German Respiratory Society , Swiss Exchange , Committee For Medicinal Products Human , European Medicines Agency , Idorsia Pharmaceuticals Ltd , Health Canada , German Society For Clinical Neurophysiology , German Cardiac Society , Medicinal Products , Human Use , Lancet Neurology , Paul Clozel , Chief Executive Officer , Vita Salute San Raffaele University , Insomnia Daytime Symptoms , Impacts Questionnaire , European Economic Area , Interdisciplinary Center , Sleep Medicine , German Society , Clinical Neurophysiology , American Association , Berlin Brandenburg , German Sleep , Professor Fietze , State University , Sleep Disorders Center , Baylor College , Postgraduate Degree , Scientific Instituteh San Raffaele Turro , Field Editor , Editorial Board , European Journal , Sleep Research , Italian Association , World Association , Statistical Manual , Mental Disorders , Discov Today Dis , Clin Sleep , Idorsia Pharmaceuticals , Vice President , Investor Relations , Pharmaceuticals Ltd , Idorsia , Pharmaceuticals , Quviviq , Daridorexant , Ecommended , Approval , Europe , Treatment , Adults , Insomnia , Disorder ,

© 2025 Vimarsana